Department of Internal Medicine, Mayo Clinic, 13737 North 92nd Street, Scottsdale, Phoenix, AZ 85260, United States.
Mayo Clinic, Phoenix, AZ, United States.
Am J Med. 2022 Jul;135(7):e145-e149. doi: 10.1016/j.amjmed.2022.03.006. Epub 2022 Apr 1.
Multicancer early detection panels have recently become available to patients with a provider's prescription and an out-of-pocket fee. Beyond theoretical modeling, little is known about how these assays will impact primary care practices despite a high likelihood that primary care providers (PCPs) will be ordering these tests with some frequency. In particular, there are concerns about patient counseling, costs, frequency of testing, patient anxiety, and subsequent testing for a positive result. This review aims to appraise the current literature and provide a framework that PCPs can use to discuss these tests with patients and streamline their ordering, interpretation, and overall use into everyday practice.
多癌种早期检测面板最近已经可以在有提供者处方和自费的情况下提供给患者。尽管初级保健提供者 (PCP) 很可能会经常订购这些测试,但除了理论建模之外,对于这些测试将如何影响初级保健实践,我们知之甚少。特别是,人们对患者咨询、成本、测试频率、患者焦虑以及阳性结果的后续测试表示担忧。本综述旨在评估当前的文献,并提供一个框架,供 PCP 用于与患者讨论这些测试,并简化他们的订购、解释和整体使用,使其成为日常实践的一部分。